Tailored axillary treatment after neoadjuvant systemic...

Tailored axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer patients is safe: 3-year follow-up of the MARI protocol

Van Loevezijn, A., van der Noordaa, M.E.M., van Duijnhoven, F., Groen, E.J., Stokkel, M.P.M., Loo, C.E., Elkhuizen, P., Russell, N.S., Vrancken-Peeters, M.J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
138
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(20)30538-4
Date:
October, 2020
File:
PDF, 75 KB
2020
Conversion to is in progress
Conversion to is failed